Electrophysiologic Measures of Treatment Response in Alzheimer Disease

Completed · Phase 4

Conditions studied: Alzheimer Disease

In brief

The main purpose of this study is to determine the electrophysiological effects of cholinergic therapy (cholinesterase inhibitors and transdermal nicotine) in Alzheimer disease. The attempt will be to locate electrophysiological markers and predictors of cognitive and clinical treatment response.

Key facts

Study ID

NCT00018278

Run by

US Department of Veterans Affairs

Starts

1998-10-01

Expected to finish

2001-09-01

Last updated by the study team

2009-01-21

Who can join

Age: 55 and older, up to 85. Sex: any. Healthy volunteers: accepted.

Where it is running

• Department of Veterans Affairs — San Diego, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.